AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 265: R453-R459, 1993;
0363-6119/93 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Take, S.
Right arrow Articles by Hori, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Take, S.
Right arrow Articles by Hori, T.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 265, Issue 2 453-R459, Copyright © 1993 by American Physiological Society

ARTICLES

Central interferon-alpha inhibits natural killer cytotoxicity through sympathetic innervation

S. Take, T. Mori, T. Katafuchi and T. Hori
Department of Physiology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

The brain has been known to produce high levels of interferon-alpha (IFN-alpha) during viral infections. We investigated the central and peripheral mechanisms of the brain IFN-alpha-induced suppression of natural killer (NK) cytotoxicity in the rat. The activity of NK cells in the spleen and the peripheral blood decreased 30-120 min after intracerebroventricular (icv) injection of recombinant human IFN-alpha of > 1,000 U but not after its intraperitoneal injection. This effect was antagonized by pretreatment with icv naltrexone (NLTX). Splenic denervation was observed to completely abolish the IFN-alpha-induced suppression of NK activity, whereas bilateral adrenalectomy did not. Furthermore, this immunosuppression was blocked by an icv injection of an antagonist of corticotropin-releasing factor (CRF), alpha-helical CRF-(9-41). The icv injection of CRF resulted in reduced NK activity, which was not affected by NLTX. The results suggest that brain IFN-alpha activates the CRF system through central opioid receptors and thereby suppresses the NK cytotoxicity predominantly through splenic sympathetic innervation.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
C. K. Ganta, N. Lu, B. G. Helwig, F. Blecha, R. R. Ganta, L. Zheng, C. R. Ross, T. I. Musch, R. J. Fels, and M. J. Kenney
Central angiotensin II-enhanced splenic cytokine gene expression is mediated by the sympathetic nervous system
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1683 - H1691.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. W. Renton and T. E. Nicholson
Hepatic and Central Nervous System Cytochrome P450 Are Down-Regulated during Lipopolysaccharide-Evoked Localized Inflammation in Brain
J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 524 - 530.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. H. Straub, M. Dorner, J. Riedel, M. Kubitza, N. Van Rooijen, B. Lang, J. Scholmerich, and W. Falk
Tonic neurogenic inhibition of interleukin-6 secretion from murine spleen caused by opioidergic transmission
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1998; 274(4): R997 - R1003.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online